© 2024 Connecticut Public

FCC Public Inspection Files:
WEDH · WEDN · WEDW · WEDY · WNPR
WPKT · WRLI-FM · WEDW-FM · Public Files Contact
ATSC 3.0 FAQ
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

How Yale's 3D Printing Venture Could Solve the Organ Donor Problem

Organovo
/
Yale University
A 3D bioprinted blood vessel.
It may sound like a bit of science fiction, but 3D bioprinting has been around for seven years.

Worldwide, the number and quality of vital organ donors has decreased. Yale University has announced a new venture with a 3D biology company to develop 3D-printed tissue and organs.

So, how do you build a new liver or kidney using a 3D printer?

Dr. John Geibel, vice chair and director of surgical research at Yale School of Medicine, said to think of your old inkjet printer. "In this case, the cartridges are filled with either cellular material, or some of these gel-like, matrigel, hydragel materials that is going to be the jelly-like foundation that holds the cells in place while the organ is being printed."

Geibel said the gel acts as scaffolding, or the frame of a house, a place where the cells grow into a new organ.

It may sound like a bit of science fiction, but 3D bioprinting has been around for seven years. While transplant-ready, 3D-printed organs may be years off, the technology has already yielded various transplantable tissue and vascular grafts.

Geibel said that when the technology is up and running, 3D-printed organ transplants will be better than donor transplants. "Not only that it's going to provide organs," he said, "it's going to provide organs that are coming from cellular material from the individual. Then many of these immunotoxicity drugs that have to go along with the transplant -- which can have serious side effects -- will fall by the wayside."

Yale School of Medicine's Department of Surgery and the School of Engineering and Applied Science will work together with Organovo, a 3D biology company that already has printed a small, fully-functional liver for the purpose of pharmaceutical testing.

Ray Hardman is Connecticut Public’s Arts and Culture Reporter. He is the host of CPTV’s Emmy-nominated original series Where Art Thou? Listeners to Connecticut Public Radio may know Ray as the local voice of Morning Edition, and later of All Things Considered.

Stand up for civility

This news story is funded in large part by Connecticut Public’s Members — listeners, viewers, and readers like you who value fact-based journalism and trustworthy information.

We hope their support inspires you to donate so that we can continue telling stories that inform, educate, and inspire you and your neighbors. As a community-supported public media service, Connecticut Public has relied on donor support for more than 50 years.

Your donation today will allow us to continue this work on your behalf. Give today at any amount and join the 50,000 members who are building a better—and more civil—Connecticut to live, work, and play.

Related Content